SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000921895-23-002708
Filing Date
2023-12-04
Accepted
2023-12-04 16:33:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422sabs_12042023.htm SC 13G 282267
2 JOINT FILING AGREEMENT ex991to13g07422sabs_12042023.htm EX-99.1 8414
  Complete submission text file 0000921895-23-002708.txt   292371
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Subject) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92283 | Film No.: 231463697
SIC: 2836 Biological Products, (No Diagnostic Substances)